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Introduction 
             Febrile illnesses in infants and children account for 20% of 
paediatric visits.
1,2
Various set temperatures have been used to define 
fever, but commonly accepted definition for   fever is   temperature of > 
38.08C (100.48F). This value derived from studies done by Wunderlich, 
who took 1 million measurements on 25,000 patients and proposed that 
this temperature was the upper limit ofnormal
3
. Though there is less 
invasive means of measuring temperature exist, such as axillary and aural 
thermometry, there is a difference in measurements exists.
4,5
it warrants 
using the current outpatient reference standard, rectal thermometry, when 
measuring temperatures in young children. An accurate temperature 
measurement is especially important if one chooses to use fever 
guidelines, because the implementation of these guidelines is initiated 
once a patient meets a certain temperature threshold.Fever occurs when 
infectious and non infectious process interacts with the host defence 
mechanism. 
The pattern of temperature changes may occasionally hint at the 
diagnosis: 
 Continuous fever: Temperature remains above normal throughout 
the day and does not fluctuate more than 1 °C in 24 hours, e.g.lobar 
pneumonia, typhoid, urinary tract infection, brucellosis, or typhus. 
Typhoid fever may show (Wunderlich curve of typhoid fever), with 
a slow stepwise increase and a high plateau. (Drops due to fever-
reducing drugs are excluded.) 
 Intermittent fever: The temperature elevation is present only for a 
certain period, later cycling back to normal, e.g.malaria, kala-azar, 
pyaemia, or septicemia.  
 
 Following are its types 
o Quotidian fever, with a periodicity of 24 hours, typical of 
Malaria 
o Tertian fever (48 hour periodicity), typical of Malaria 
o Quartan fever (72 hour periodicity), typical of Plasmodium 
malariae. 
 Remittent fever: Temperature remains above normal throughout 
the day and fluctuates more than 1 °C in 24 hours, e.g., infective 
endocarditis. 
 Pel-Ebstein fever: A specific kind of fever associated with 
Hodgkin's lymphoma, being high for one week and low for the 
next week and so on. However, there is some debate as to whether 
this pattern truly exists.
6
 
          Body temperature is regulated by thermo sensitive neurons located 
in the preoptic or anterior hypothalamus that respond to changes in blood 
temperature as well as cold and warm receptors located in skin and 
muscles. A trigger of the fever, called a pyrogen causes a release of 
prostaglandin E2 (PGE2). PGE2 then in turn acts on the hypothalamus, 
which generates a systemic response back to the rest of the body, causing 
heat-creating effects to match a new temperature level. 
In many respects, the hypothalamus acts like a thermostat.
7
When the set 
point is raised, the body rises its temperature by both active generation of 
heat and retaining heat. Vasoconstriction causes reduction in heat loss 
through the skin and person to feel cold. If these are insufficient to make 
the blood temperature in the brain match the new setting in the 
hypothalamus, then shivering produce more heat by muscle movements. 
once fever stops, and the hypothalamic setting is set lower; the reverse of 
these processes (vasodilation, end of shivering and non shivering heat 
production) and sweating are used to cool the body to the new, lower 
setting. 
          A pyrogen is a substance that induces fever. These can be either 
internal (endogenous) or external (exogenous) to the body. Major 
endogenous pyrogens are interleukin 1 (α and β),8  interleukin 6 (IL-6) 
and tumor necrosis factor-alpha. Minor endogenous pyrogens include 
interleukin-8, tumor necrosis factor-α, tumor necrosis factor-β, 
macrophage inflammatory protein-α and macrophage inflammatory 
protein-β as well as interferon-α, interferon-β, and interferon-γ.8Some 
substances produced within the body are not pyrogens but are capable of 
stimulating endogenous pyrogens. Such substances include antigen-
antibody complexes in the presence of complement, complement 
components, lymphocyte products, bile acids, and androgenic steroid 
metabolites.
15
 
          The bacterial substance lipopolysaccharide (LPS), present in the 
cell wall of some bacteria, is an example of an exogenous pyrogen. 
Pyrogenicity may vary: In extreme examples, some bacterial pyrogens 
known as superantigens can cause rapid and dangerous fevers. In essence, 
all endogenous pyrogens are cytokines, molecules that are a part of the 
innate immune system. They are produced by phagocytic cells and cause 
the increase in the thermoregulatory set-point in the hypothalamus. 
         Many drugs cause fever, and the mechanism for increasing body 
temperature varies with the class of drugs. Drugs that are known to cause 
fever include vancomycin, amphotericin B, and allopurinol. Along with 
infectious diseases and drugs, malignancy and inflammatory diseases can 
cause fever through the production of endogenous pyrogens.
16
 
        Heat production exceeding heat loss is the second mechanism that 
leads to fever, with examples including salicylate poisoning and 
malignant hyperthermia. Defective heat loss is the third mechanism of 
fever genesis, for example, in children with ectodermal dysplasia or 
victims of severe heat exposure 
        There are arguments for and against the usefulness of fever, In 
theory, fever can aid in host defense. There are some important 
immunological reactions that are speed up by temperature, and some 
pathogens with strict temperature preferences could be suppressed. 
Research has demonstrated that fever has several important functions in 
the healing process: 
 Increased mobility of leukocytes 
 Enchanced leukocytes phagocytosis 
 Endotoxin effect decreasedIncreased 
  proliferation of leukocytes     
 
       The management of the febrile young child continues to evolve. 
Epidemiology of bacterial infections varies considerably. In united states 
Haemophilus influenza which was previously presented as significant 
pathogen resulting in substantial morbidity and mortality in young 
children. Haemophilus influenza was of all positive cultures 19% of 
febrile children who presented to a pediatric walk-in clinic in 1972
9
, but 
after Hemophilus influenzae type b vaccine the epidemiology of invasive 
bacterial disease changed dramatically. H influenzae type b has been 
almost eliminated with a 94% decline in H influenzae meningitis shortly 
afterthe introduction of the Hib vaccine.
10,11
 Combining the results of two 
largest studies of occult bacteremia in patients seen in the mid 1990s in 
Boston and Philadelphia,  no blood cultures  grew H. influenzae from 
15,366patients. 
          Differential diagnosis of fever is quite broad and includes both 
infectious and noninfectious causes,
12
 the most of febrile children have 
underlying infectious causes of fever. Diagnostic strategies stress the 
detection of bacterial disease since bacterial diseases are more likely to be 
associated with worse outcomes, but even viral infections can also be 
associated with significant morbidity and mortality, especially in younger 
children. 
Fever in children may be categorised as 
1. Fever due to infection without Focus (no rash) 
2. Fever with localised sign (no rash) 
3. Fever with rash. 
          Fever without a focus refers to a rectal temperature of 38
o
C or 
higher as the sole presenting feature. The terms ―fever without localizing 
signs‖ and ―fever of unknown origin‖ (FUO) are subcategories of fever 
without a focus. 
The majority of these children who present with fever are younger than 3 
years. Most children have an apparent source of infection (ie, a viral 
respiratory infection, acute otitis media, or enteritis). Both minor and life 
threatening infectious diseases, including viral respiratory infections and 
bacterial meningitis are most common in this age group. However, in 
20% of the cases
1
, the paediatrician may not able to identify focus of the 
infection  by the patient‘s clinical history and detailed clinical 
examination. This is called fever without source (FWS).
13,14
  
          Occult bacteremia (bacteremia without an apparent infection) 
occurs in 1.5% of relatively well-appearing children between 1-36 mo of 
age with fever.  Without treatment occult bacteremia may subside 
spontaneously with sequelae, may persist or may lead to localized 
infections, such as meningitis, pneumonia, cellulites, or suppurative 
arthritis. The pattern of sequelae may be related to host factors and the 
offending organism. In some children, the occult bacteremic illness can 
represent the early signs of serious localized infection rather than a 
transient disease state. 
 
 
 
Fever without Localizing Signs  
            Fever of acute onset, with duration of <1 wk and without 
localizing signs, is a common diagnostic dilemma in children <36 mo of 
age. The aetiology and evaluation of fever without localizing signs 
depends on the age of the child. Usually three 3 age groups are 
considered: neonates or infants to 1 mo of age, infants >1 month to 
3 month of age, and children >3 month to 3 year of age. Many guidelines 
were published to aid in evaluating the healthy 0 to 36 mo old with fever 
without a source. But after the use of conjugate Haemophilus influenzae 
type b (Hib) and Streptococcus pneumoniae vaccines, the rates of 
infections with these 2 pathogens have decreased dramatically
17
. As a 
result modifications of the 1993 guidelines have been advocated. 
Children in high-risk groups need to be treated aggressively.   
FEBRILE PATIENTS AT INCREASED RISK FOR SERIOUS 
BACTERIAL INFECTIONS
18
 
RISK GROUP DIAGNOSTIC CONSIDERATIONS 
IMMUNOCOMPETENT PATIENTS 
Neonates (<28 days) 
Sepsis and meningitis caused by group B 
streptococcus, Escherichia coli, Listeria 
monocytogenes;  
neonatal herpes simplex virus infection, 
RISK GROUP DIAGNOSTIC CONSIDERATIONS 
enteroviruses 
Infants 1to3 mo 
Serious bacterial disease occurs in 10-15%, 
including bacteremia in 5%; urinary tract 
infection 
Infants and children 3 to 
36 mo 
Occult bacteremia in <0.5% of children 
immunized with both Haemophilus influenzae 
type b and pneumococcal conjugate vaccines; 
urinary tract infections 
Hyperpyrexia (>40
o
C) 
Meningitis, bacteremia, pneumonia, heatstroke, 
hemorrhagic shock-encephalopathy syndrome 
Fever with petechiae 
Bacteremia and meningitis caused by Neisseria 
meningitidis, H. influenzae type b, and 
Streptococcus pneumoniae 
IMMUNOCOMPROMISED PATIENTS 
Sickle cell disease 
Sepsis, pneumonia, and meningitis caused by S. 
pneumoniae, osteomyelitis caused by 
Salmonella and Staphylococcus aureus 
RISK GROUP DIAGNOSTIC CONSIDERATIONS 
Asplenia 
Bacteremia and meningitis caused by N. 
meningitidis, H. influenzae type b, and S. 
pneumonia 
Complement or 
properdin deficiency 
Sepsis caused by N. meningitides 
Agammaglobulinemia Bacteremia, sinopulmonary infections 
AIDS 
S. pneumoniae, H. influenzae type b, and 
Salmonella infections 
Congenital heart disease 
Infective endocarditis; brain abscess with right-
to-left shunting 
Central venous line 
Staphylococcus aureus, coagulase-negative 
staphylococci, Candida 
Malignancy 
Bacteremia with gram-negative enteric bacteria, 
S. aureus, and coagulase-negative 
staphylococci; fungemia with Candida and 
Aspergillus 
 
 
 
 
 Neonates  
    Neonates with fever without focus are greatest challenge to evaluate 
because of   limited signs of infection, making it difficult to clinically 
differentiate between a serious bacterial infection and self-limited viral 
illness. Immaturity of the immune responses in first few months of life 
also increases the significance of fever in the young infant. In neonates 
with fever and do not appear ill have a 7% risk of having a serious 
bacterial infection. Although neonates can have community acquired 
infection, they are mainly at risk for late-onset neonatal bacterial diseases 
(group B streptococci, Escherichia coli, and Listeria monocytogenes) and 
perinatally acquired herpes simplex virus (HSV) infection. 
Practice guidelines recommend that if a neonate who had fever recorded 
at home by a reliable parent, the patient must be considered as a febrile 
neonate. Because of unreliable physical findings and the presence of an 
immature immune system, all febrile neonates should be hospitalized; 
blood, urine, and cerebrospinal fluid (CSF) should be cultured. Child 
should be given empirical intravenous antibiotics. CSF studies should 
include cell counts, glucose and protein levels, Gram stain, and culture; 
HSV and entero virus polymerase chain reaction should be considered. 
Stool culture and chest radiograph also to be done as the part of the 
evaluation. Combination of antibiotics such as ampicillin and cefotaxime 
are recommended. Acyclovir should be included if HSV infection is 
suspected owing to the presence of CSF pleocytosis or known maternal 
history of genital HSV, especially at the time of delivery. 
1 Month to 3 Months  
                 Majority of the children with fever without localizing signs in 
the age group of 3-12 months likely have a viral syndrome. In contrast to 
bacterial infections, viral diseases  may have a distinct seasonal pattern: 
respiratory syncytial virus and influenza A virus infections commonly 
seen during the winter. Enterovirus infections usually occur in the 
summer and fall. Although a viral infection is the most likely etiology, 
fever in these children should always suggest the possibility of serious 
bacterial disease. Organisms may include group B streptococcus, 
L.monocytogenes, Salmonella enteritis, E. coli, Neisseria meningitidis, S. 
pneumoniae, Hemophilus influenza  and Staphylococcus aureus. 
Pyelonephritis is common in uncircumcised infant boys and infants with 
urinary tract anomalies. Other potential bacterial diseases include otitis 
media, pneumonia, omphalitis, mastitis, and other skin and soft tissue 
infections. 
            Ill-appearing (toxic) febrile infants ≤3 mo of age should be 
hospitalised and immediate parenteral antimicrobial therapy after cultures 
of blood, urine, and CSF are obtained. Ampicillin to cover L. 
monocytogenes and enterococcus) plus either ceftriaxone or cefotaxime is 
an initial antimicrobial regimen for ill-appearing infants in this age group. 
This regimen is effective against the usual bacterial pathogens causing 
sepsis, urinary tract infection, and enteritis in young infants. However, if 
meningitis is suspected because of CSF abnormalities, vancomycin 
should be included to treat possible penicillin-resistant S. pneumoniae 
until the results of culture and susceptibility tests are known. 
             Many academic institutions have studied the optimal 
management of low-risk patients in this age group with fever without a 
focus. The use of viral diagnostic studies (enteroviruses, respiratory 
viruses, rotavirus, and herpesvirus) in combination with the Rochester 
Criteria or similar criteria can enhance the ability to determine which 
infants are at high risk for serious bacterial infections. In Febrile infants 
where a virus has been detected are at low or no risk of a serious bacterial 
infection. Well-appearing infants 1-3 mo of age can be managed using 
low-risk laboratory and clinical criteria and if reliable parents are 
involved and close follow-up is assured.  
 
  LOW RISK CRITERIA IN 1-3 MONTHS OLD WITH FEVER
18
 
BOSTON CRITERIA 
Infants are at low risk if they appear well, have normal physical 
examination, have a caretaker reachable by telephone, and laboratory 
tests are as follows: 
   •     CBC: <20,000 WBC/mm3 
   •     Urine: negative leukocyte esterase 
   •     CSF: leukocyte count less than 10 x106/L, 
 
PHILADELPHIA PROTOCOL 
Infants are at low risk if they appear well, have a normal physical 
examination, and laboratory tests are as follows: 
   •     CBC: <15,000 WBC/mm3; band: total neutrophil ratio <0.2 
   •     Urine: <10 WBC/HPF; no bacteria on Gram stain 
   •     CSF: <8 WBC/mm3; no bacteria on Gram stain 
   •     Chest radiograph: no infiltrate 
   •     Stool: no RBC; few to no WBC 
 
PITTSBURGH GUIDELINES 
Infants are at low risk if they appear well, have a normal physical 
examination, and laboratory tests are as follows: 
   
•     CBC: 5,000-15,000 WBC; peripheral absolute band count 
<1500/mm
3
 
   
•     Urine (enhanced urinalysis): 9 WBC/mm3 and no bacteria on Gram 
stain 
   
•     CSF: 5 WBC/mm3 and negative Gram stain; if bloody tap, then 
WBC  :  RBC ≤ 1  :  500 
   •     Chest radiograph: no infiltrate 
   •     Stool: 5 WBC/HPF with diarrhea 
 
ROCHESTER CRITERIA 
Infants are at low risk if they appear well, have a normal physical 
examination, and laboratory findings are as follows: 
   •     CBC: 5,000-15,000 WBC/mm3; absolute band count ≤1500/mm3 
   •     Urine: <10 WBC/HPF at 40x 
   •     Stool: <5 WBC/HPF if diarrhea 
 
          Infants 1-3 mo of age with fever who appear generally well; who 
have been previously healthy; who have no evidence of skin, soft tissue, 
bone, joint, or ear infection; and who have a peripheral white blood cell 
(WBC) count of 5,000-15,000 cells/mm
3
, an absolute band count of 
<1,500 cells/mm
3
 and normal urinalysis and negative culture (blood and 
urine) results are unlikely to have a serious bacterial infection. The 
negative predictive value with 95% confidence of these criteria for any 
serious bacterial infection is >98% and for bacteremia is >99%. Among 
serious bacterial infections, pyelonephritis is the most common and may 
be seen in well-appearing infants who have fever without a focus or in 
those who appear ill. Urinalysis may be negative in infants <2 mo of age 
with pyelonephritis. Bacteremia may be present in <30% of infants with 
pyelonephritis. 
         The decision to obtain CSF studies in the well-appearing 1-3 mo old 
infant depends on the decision whether to administer empirical antibiotics 
or not. A lumbar puncture may be deferred. When close observation 
planned without antibiotics. If the child deteriorates clinically, a full 
sepsis evaluation should be performed, and intravenous antibiotics should 
be administered. When empirical antibiotics are initiated, CSF studies 
should be obtained, preferably before administering antibiotics.
20 
 
3 Months to 36 Months of Age  
          Nearly 30% of febrile children in the 3-36 mo age group have no 
localizing signs of infection. Viral infections are the major cause of fevers 
in this population, but serious bacterial infections do occur and are caused 
by the same pathogens listed for patients 1-3 mo of age, except those 
acquired perinatally, S. pneumoniae, N. meningitidis, and Salmonella 
account for most cases of occult bacteremia. Hib was an important cause 
of occult bacteremia in young children before universal immunization 
with conjugate Hib vaccines and remains common in underdeveloped 
countries that have not implemented these vaccines. 
           Risk factors for increased probability of occult bacteremia include 
temperature ≥39oC, WBC count ≥15,000/mm3, and elevated absolute 
neutrophil count, band count, erythrocyte sedimentation rate, or C-
reactive protein. The incidence of bacteremia and /or pneumonia or 
pyelonephritis, among infants 3-36 mo of age increases as the 
temperature (especially >40
o
C) and WBC count (especially >25,000) 
increase
19
. However, no combination of laboratory tests or clinical 
assessment is accurate in predicting the presence of occult bacteremia. 
Socioeconomic status, race, sex, and age (within the range of  3-36 mo) 
do not appear to affect the risk for occult bacteremia.
19 
          In some children, the occult bacteremic illness can represent the 
early signs of serious localized infection rather than a transient disease 
state. Hemophilus  bacteremia is characteristically associated with a 
higher risk for localized serious infection than is bacteremia due to S. 
pneumoniae. Hospitalized children with Hemophilus bacteremia often 
develop focal infections, such as meningitis, epiglottitis, cellulitis, 
pericarditis, or osteoarticular infection, and spontaneous resolution of 
bacteremia is rare. In patients with pneumococcal bacteremia (occult or 
focal), spontaneous resolution occurs in 30-40%, with a higher rate of 
spontaneous resolution among well-appearing children. 
           Important bacterial infections among children 3-36 mo of age with 
localizing signs include otitis media, sinusitis, pneumonia (not always 
evident without a chest x-ray), enteritis, urinary tract infection, 
osteomyelitis, and meningitis. 
          Treatment of toxic-appearing febrile children 3-36 mo of age who 
do not have focal signs of infection includes hospitalization and prompt 
institution of antimicrobial therapy after specimens of blood, urine, and 
CSF are obtained for culture. Consensus practice guidelines published in 
1993 recommended that children 3-36 mo of age who have a temperature 
of <39C and do not appear toxic be observed as outpatients without 
performing diagnostic tests or administering antimicrobial agents. For 
non toxic-appearing infants with a rectal temperature of ≥39oC, options 
include obtaining a blood culture and administering empirical antibiotic 
therapy (ceftriaxone, a single dose of 50 mg/kg, not to exceed 1 g); if the 
WBC count is >15,000/mm
3
, obtaining a blood culture and beginning 
empirical antibiotic therapy; or obtaining a blood culture and observing as 
outpatients without empirical antibiotic therapy, with return for re-
evaluation within 24 hr. 
          Guidelines for managing febrile children 3-36 mo of age who have 
received both Hib and S. pneumoniae conjugate vaccines have not been 
established, but careful observation without empirical administration of 
antibiotic therapy is generally prudent. Since fully vaccinated young 
children are at a much lower risk of occult bacteremia and meningitis as 
the cause of acute fever without localizing signs, some advocate that the 
only laboratory tests needed in this age group when temperature is >39
o
C 
are a urinalysis and urine culture for circumcised boys <6 mo of age and 
uncircumcised boys and all girls <24 mo of age. Regardless of the 
management option the family should be instructed to return immediately 
if the child's condition deteriorates or new symptoms develop.  
MANAGEMENT OF FEVER WITHOUT LOCALIZING SIGNS
18
 
GROUP MANAGEMENT 
Any toxic-
appearing child 
0-36 mo and 
temperature 
≥38oC 
Hospitalize, broad cultures plus other tests,* parenteral 
antibiotics 
Child <1 mo 
and 
temperature 
≥38oC 
Hospitalize, broad cultures plus other tests,* parenteral 
antibiotics 
Child 1-3 mo 
and 
temperature 
≥38oC 
   
 Two-step process 
   
1     Determine risk based on history, physical 
examination, and laboratory studies. 
GROUP MANAGEMENT 
Low risk:  
   •     Uncomplicated medical history 
   •     Normal physical examination 
   
•     Normal laboratory studies  
   
•     Urine: negative leukocyte 
esterase, nitrite and <10 
WBC/HPF 
   
•     Peripheral blood: 5,000-15,000 
WBC/mm
3
; <1,500 bands or 
band  :  total neutrophil ratio 
<0.2 
   
•     Stool studies if diarrhea (no RBC 
and <5 WBC/HPF) 
   
•     CSF cell count (<8 WBC/mm3) 
and negative Gram stain 
   
•     Chest radiograph without 
infiltrate 
 
 
   
2     If child fulfills all low-risk criteria, 
administer no antibiotics, ensure follow-up in 
GROUP MANAGEMENT 
24 hr and access to emergency care if child 
deteriorates. Daily follow-up should occur 
until blood, urine, and CSF cultures are final. 
If any cultures are positive, child returns for 
further evaluation and treatment. If child 
does not fulfill all low-risk criteria, 
hospitalize and administer parenteral 
antibiotics until all cultures are final and 
definitive diagnosis determined and treated. 
 
 
Child 3-36 mo 
and 
temperature 38-
39
o
C 
Reassurance that diagnosis is likely self-limiting viral 
infection, but advise return with persistence of fever, 
temperatures >39
o
C, and new signs and symptoms 
Child 3-36 mo 
and 
temperature 
>39
o
C 
   
 Two-step process:  
   1     Determine immunization status 
   
2     If received conjugate pneumococcal and H. 
influenzae type b vaccines, obtain urine 
studies (urine WBC, leukocyte esterase, 
nitrite, and culture) for all girls, all boys 
GROUP MANAGEMENT 
<6 mo old, all uncircumcised boys <2 yr, all 
children with recurrent urinary tract 
infections 
 
If did not receive conjugate pneumococcal and H. 
influenzae type b vaccines, manage according to the 
1993 Guidelines  
 
          Empirical antibiotic therapy in well-appearing children <36 mo of 
age who have not received Hib and S. pneumoniae conjugate vaccines 
and who have a rectal temperature of >39
o
C and a WBC count of 
>15,000/mm
3
 is strongly recommended. If blood cultures are obtained 
and S. pneumoniae is isolated from the blood, the child should return to 
the physician as soon as possible after the culture results are known. If the 
child appears well, is afebrile, and has a normal physical exam, a second 
blood culture should be obtained and the child should be treated with 7-
10 days of oral antimicrobial therapy. If the child appears ill and 
continues to have fever with no identifiable focus of infection at the time 
of follow-up, or if Hemophylus . influenzae, or N. meningitidis is present 
in the initial blood culture, the child should have a repeat blood culture, 
be evaluated for meningitis (including lumbar puncture), and receive 
treatment in the hospital with appropriate intravenous antimicrobial 
agents. If the child develops a localized infection, therapy should be 
directed toward the likely pathogens 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Review of literature 
Fever without localising sign; 
Although incidence of the cause of the fever in children may vary, most 
investigators found that infections predominate in this age group. Among 
the infections viral illness predominates. 
               B. M. Machado et al
21
conducted prospective study on 251 
children and, of these, 215 were followed up until the final diagnosis. 
Toxemia was present  in 20 children, and 195 were well-appearing (30 up 
to 3 months old and 165 from 3 to 36 months old). Among thosechildren 
from 3 to 36 months without toxemia, 95 had axillary temperature > 39 
ºC. In 107 (49.8%) children, spontaneous resolution of fever; in 88 
(40.9%), benign self-limited disease was identified; and in 20 (9.3%), had 
SBI. Among the cases of SBI, they identified 16 cases of urinary tract 
infections, three cases of pneumonia and one occult bacteremia. 
Conclusion: They concluded that guideline was shown to be appropriate 
to follow up these children using simple laboratory tests that can be 
carried out at most health facilities. The most frequent SBI in this sample 
was urinary tract infection. 
         Robert H. et a
22
l  in a Prospective cohort study studied 3066 infants 
aged 3 months or younger with temperatures of at least 38°C. The PROS 
clinicians hospitalized 36% of the infants, performed laboratory testing in 
75%, and initially treated 57%with antibiotics. The majority (64%) were 
treated exclusively outside of the hospital. Bacteremia was detected in 
1.8% of infants (2.4% of those tested) and bacterial meningitis in 0.5%. 
Well-appearing infant‘s aged 25 days or older with fever of less than 
38.6°C had a rate of 0.4% for bacteremia/bacterial meningitis. Frequency 
of other illnesses included urinary tract infection, 5.4%; otitis media, 
12.2%; upper respiratorytract infection,25.6%; bronchiolitis,7.8%; and 
gastroenteritis,7.2%. Conclusions : Pediatric clinicians in the United 
Statesuse individualized clinical judgment in treating febrile infants. In 
this study, relying on current clinical guidelines would not have improved 
care but would have resulted in more hospitalizations and laboratory 
testing. 
Vinchurkar S
23
who studied 102 children in baoda in 2002 between the 
ages 0 and 36 months in 2002.37 (36.2 percent) out of 102 had bacterial 
infection, while 65 (63.8 percent) had non-bacterial illness. Staph.Aureus 
was the common aetiologic agent identified in blood culture.  
          Z. Nademi el al 
24
studied One hundred and forty one children  in 
between 8 days and 16 years of age were studied, 64% male, 55% aged 
under 2 years. Eighty three percent had of children had temperatures 
between 38 and 39°C. Twenty nine percent (41/141) had serious disease 
but microbiologically or radiologically proven in only 22% (31/141); 
pneumonia (nine), meningitis (seven), sepsis (five), urinary tract infection 
(five), brain abscess (two), toxic shock syndrome (one), appendicitis 
(one), ischiorectal abscess (one). Forty two percent (5/12) of 
microbiologically proven meningitis and sepsis and 36% (8/22) of all 
meningitis and sepsis were due to meningococcal. Seventy one percent 
had non-serious diseases. In cases of serious disease the temperature was 
>39°C in 15% (sensitivity: 14%, specificity: 82%, PPV: 25%). Poor 
feeding and restlessness predicted serious disease with a sensitivity of 
78% and 76%, respectively. Full blood count (FBC) was taken in 50% of 
patients on admission; in 44% of serious and 24% of non-serious diseases 
WBC was between 5000 and 15 000/mm
3
 and WBC ≥15 000/mm3 was 
seen in 39% of serious diseases (sensitivity:10%, specificity: 95%, PPV: 
44%).Conclusions: One out of three of children referred with fever had a 
serious disease. Degree of temperature and WBC count were poor 
predictors of serious disease. Interestingly, poor feeding and restlessness 
were more sensitive predictors, suggesting high fever and WBC count 
cannot replace clinical assessment of the child with a temperature. 
         George O. Akpede,
25
conducted a prospective study in Six-hundred-
and-forty-two previously healthy children aged 1 month to 5 years with 
fever of acute onset, without localizing signs of infection, over 1 year. 
Sixty-three per cent had malaria, 4 per cent bacteraemia, and 7 percent 
malaria and bacteraemia. Neither infection was identified in 27 per cent. 
Malaria was the predominant infection irrespective of season, 
temperature on presentation, or age (except under 6 months). Gram-
negative bacteraemia was overall commoner than Grampositive 
bacteraemia. But Staphylococcus aureus was the single most  common 
organism (43 per cent) in bacteremia. The prevalence of malaria 
increased with age while that of bacteraemia decreased with age (P< 
0.0005). The prevalence of an identifiable infection increased with the 
temperature on presentation (P< 0.025). conclusion:  although malaria is 
the predominant infection in previously healthy under-5 children with 
acute fever without specific localizing signs of infection, bacteraemia 
(alone or associated with malaria) occur with an importantly high 
frequency. It is recommended that while presumptive treatment for 
malaria is justified in such children, evaluation for bacteraemia should be 
given consideration.  
            Richard et al 
26
studied the prevalence of occult bacteremiain 
infants. Of 52 toxic infants involved in the study, an infectious source, 
commonly otitis media, was found in 26 (50%). Eighteen patients (35%) 
had WBC counts above 15,000. Bacteremia was documented in six 
patients (12%), due to Streptococcus pneumoniae in five and group C 
Streptococcus in one.  
Walsh et al
27
Between September, 1996, and August, 1997, processed 
2123 cultures. Of these, 365 (17.2%) grew a pathogen. Non-typhi 
salmonellae (NTS) and enteric Gram-negative bacilli constituted 67.4% 
of isolates, and Streptococcus pneumoniae constituted 16.4%. More than 
two-thirds of NTS episodes coincided with the peak malaria transmission 
season (January to June); 67% of bacteremic children were malnourished, 
28% severely so. Screening tests for penicillin resistance suggested a rate 
of 21% among pneumococci. Conclusions: Bacteremia is common in 
hospitalized Malawian children and has a high mortality. There are high 
rates of resistance to some of the commonly used antibacterial agent 
             Patrick J Crocker
28
 et al studied a selected series of febrile infants 
(N = 201) in an attempt to prospectively identify risk factors for 
bacteremia.. Twenty-one infants (9.5%) had positive blood cultures. 
WBC count of more than 15,000 correlated with bacteremia, with a 
sensitivity of 0.71 and a specificity of 0.73. The combination of fever 
higher than 39.4 C present for more than 12 hours and absolute 
polymorphonuclear count of more than 9,000 cells/mm
3
 had a sensitivity 
of 0.62 and a specificity of 0.78 for bacteremia.  
John E. MCGowan et al showed clinically important bacterial pathogens 
in the blood from 31 of 708 children in a three-month period. 
Diplococcus pneumoniae and Haemophilusinfluenzae were the most 
frequent of seven species identified. Bacteremia was most frequent in 
children seven to 12 months old (p<0.001) and was associated with a 
white-cell count of 20,000 or more (p<0.01) and a temperature of 39.4°C 
or higher (p<0.01). 
          Morris CM,et al 
29
conducted a prospective study to document the 
importance of urinary tract infection (UTI) as a cause of fever without a 
focus (FWF) in children less than 3 years of age. UTI was diagnosed on 
urine culture in 9 of the 98 children. Both urinary nitrite and leukocyte 
esterase tests were sensitive (89%) and specific (96%). Other causes of 
FWF were classified as non-specific viral infection (31 children), lower 
respiratory tract infection (11), malaria (7), meningitis (4), bacteraemia (1 
neonate) and other or unknown causes. The finding of UTI in 9% of the 
children is consistent with data from other tropical countries.  
    Omolola O. Ayoolaet
30
et al studied 102 infants aged 1-12 month(s) 
attending the Children‘s Emergency Ward of University College 
Hospital, Ibadan,. Over38% of the infants had bacteraemia. Escherichia 
coli (35.9%), Staphylococcus aureus(33.3%), and Klebsiella spp.(10.3%) 
of positive cultures were commonly isolated. It is concluded that, age of 
≤6 months, restlessness, and a white cell count of ≥15,000/mm3 are 
associated with a significantly increased risk of bacteraemia. 
occul Shah, Sonal
31
, studied 1866 patients 308 had no evidence of 
respiratory distress or lower respiratory tract findings and were studied 
for OP. Twenty-one patients had radiographic OP (6.8%; 95% confidence 
interval [CI], 4.0%-10.6%).Conclusion: Occult pneumonia was identified 
in 1 of 15 patients undergoing CXR without respiratory distress or 
ausculatory findings. Obtaining a CXR for the detection of OP in children 
without cough and with fever for less than 1 day in duration should be 
discouraged 
          R.K. Kaushal et al 
32
studied One hundred and thirty one children 
upto five years of age presenting with fever of >38ºC for at least 48 hours 
duration were evaluated prospectively from November 1997 to October 
1998 in the Department of Pediatrics,  Shimla showed that the  incidence 
of UTI was 8.4% (11/131). The incidence was 6.1% (5/82) in boys, 
12.2% (6/49) in girls, 12.3% (7/57) in infants and 5.4% (4/74) in 13-60 
months age group respectively.The incidence of UTI was 33.3% (5/15) 
among children presenting with urinary symptoms and 4.3% (4/94) in 
those with ARI. Of the non-urinary symptoms, diarrhea was significantly 
associated with UTI (4/20) as compared to ARI (4/94) (P <0.05). All four 
children, (2 boys and 2 girls) with diarrhea and UTI were below 24 
months. Conclusion:all acutely febrile children below 5 years with 
urinary symptoms and those below 24 months with diarrhea should be 
investigated for UTI. 
             Murphy CG
33
, Two thousand one hundred twenty-eight patients 
were studied. Among patients categorized as having no signs of 
pneumonia (n = 1,084), 5.3% (95% CI = 4.0% to 6.8%) had OP. Presence 
of cough and longer duration of cough (greater than 10 days) had positive 
likelihood ratios (LR+) of 1.24 (95% CI = 1.15 to 1.33) and 2.25 (95% CI 
= 1.21 to 4.20), respectively. Absence of cough had a negative likelihood 
ratio (LR-) of 0.19 (95% CI = 0.05 to 0.75). The likelihood of occult 
pneumonia increased with increasing duration of fever (LR+ for more 
than three days and more than five days of fever, respectively: 1.62; 95% 
CI = 1.13 to 2.31 and 2.24; 95% CI = 1.35 to 3.71). When obtained (56% 
of patients), WBC was a predictor of Occult pneumonia, with a LR+ of 
1.76 (95% CI = 1.40 to 2.22) and 2.17 (95% CI = 1.58 to 2.96) for WBC 
of >15,000/mm3 and >20,000/mm3, respectively. Conclusions: Occult 
pneumonia was found in 5.3% of patients with fever and no lower 
respiratory tract findings, tachypnea, or respiratory distress. There is 
limited utility in obtaining a CXR in febrile children without cough. The 
likelihood of pneumonia increased with longer duration of cough or fever 
or in the presence of leukocytosis 
            In a recent study, involving 500 patients leptospirosis was the 
secondcommon cause of fever contributing to 17%, following malaria 
which was 27%. Coinfectionof leptospirosis (48 cases) with malaria (220 
cases) occurred in 22% ofcases.29 Co-infection of Malaria and 
Leptospirosis has been reported from Chandigarh 
34,35
 
          Koteeswaran
36
 studied samples received between October 2004 and 
December 2004 (N=2169) indicated that the seroprevalence was found to 
be more in males (859/1499; 57.30 %) than in females (640/1499; 
42.70%). In the age-group analysis, five age groups were made separately 
for males and females; up to 5 years, 5-10 years, 10-20 years, 20-40 years 
and above 40 years. The sero positivity distribution for the above groups 
within positives were 11.41%, 12.11%, 18.16%, 40.16% and 18.16% 
among male patients and 11.25%, 11.56%, 17.19%, 34.84% and 25.16% 
among female patients. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study justification 
 Fever without localising sign is more often a diagnostic challenge 
to treating paeditriacian. 30 % of children with fever presents 
without localising sign. 
 Only very few studies are available in children with FWS in India. 
Prevalence of serious bacterial infection was not known in our 
population.  
 Most of the guideline in FWS were based on the western studies. 
This study was conducted to know the etiology of children 
presenting without localising sign in a tertiary referral centre. 
 
 
 
 
 
 
 
 
 
 
 
 Objectives of the study 
 
To know the aetiology of fever of short duration presenting without 
localising sign in the age group 1 -36 months. 
To know the common organism causing  bactremia in our children . 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Subjects  and Methods 
1)Methodology 
 Study Design : Descriptive study 
Place of study: Institute of child health and hospital for Children 
Study period: November 2009 to October 2010 
Study population: children aged 1 month to 36 months of age 
Sample size: 209 
Inclusion Criteria: Children presenting with fever of short duration (<7 days) 
with temperature of more than 38
o
 C and without any localising sign. 
Exclusion Criteria:         1. History of antibiotic intake within 48 hrs 
                                          2. Children with any immunodeficiency state 
                                          3. children with chronic illness 
Definitions: 
Fever of short duration:   Duration of fever  for < 7 days 
Toxic: A clinical appearance suggestive of serious or critical illness manifest 
by one or more of the following : some degree of inability, to interact with the 
parents or guardians, irritability, changes in the degree of consciousness, hypo 
activity, hypotonia, lethargy, hyper or hypoventilation, hypotension, 
tachycardia, signs of poor peripheral perfusion or cyanosis. 
2)  Ethics: 
                    Written informed consent was obtained from the parents and  
Institution review board clearance was obtained. 
 
3)Maneuver: 
 During the study period 837 cases was identified as having fever 
without localising sign. Among these 209 children who met inclusion 
and exclusion criteria.      
 On admission complaints, history and treatment for present illness, 
past history, socioeconomic status and immunisation status were 
recorded in the reliable Informant  
 Nutritional status and vitals were recorded. 
 A thorough clinical examination was done. Positive findings and 
relevant negative findings regarding general examination, cardio 
vascular systems, respiratory systems, gastro intestinal and central 
nervous system was noted in the proforma. 
 blood total count , differential count, Hb, platelet count,  peripheral 
smear , smear for MP, and urine microscopic examination for the 
presence of pus cells was  done in our lab for all patients. 
 Blood was taken from a peripheral vein by venepuncture sent for culture 
in all patients 
 Urine was collected by midstream clean catch and urine culture was sent 
for all patients. 
 Lumbar puncture was done in those children who had altered sensorium 
and seizures. 
  Serology for dengue was sent in suspected cases.  
 In those children who continued to have fever after 7 days further 
work up  was done to arrive at diagnosis like serology for enteric 
fever, leptospirosis. 
 All the patients with UTI ultrasound examination of the abdomen 
were done. MCU was done when indicated.  All the patients were 
followed until the final diagnosis was arrived.   
Diagnostic criteria 
Following criteria was used for establishing diagnosis 
Malaria 
a. Peripheral smear positive for malarial parasite 
b. QBC  positivity for malariae 
Urinary tract infection. 
Any one criteria 
a) midstream clean catch urine showing more than 105 colonies  
b) midstream clean catch urine showing less than 10000 colonies with 
history of antibiotic taken before culture, high fluid intake, more 
than 5 leucocytes per high power field in male child or more than 
10 leucocytes per high power field in the case of female child 
occult Pneumonia : only radiological evidence of pneumonia without 
any  lower respiratory tract sign and symptoms 
 
Bacterial meningitis. 
CSF analysis with increased cell count, raised protein, decreased sugar, 
positive CSF culture or latex agglutination 
Leptospirosis: 
Microscopic agglutination test showing titre of 1 in 100,or greater in two 
or more specimen in correlation with clinical symptoms. 
Dengue  
The World Health Organization criteria for dengue hemorrhagic fever 
are fever (2-7 days in duration or biphasic), minor or major hemorrhagic 
manifestations, thrombocytopenia (≤100,000/mm3), and objective 
evidence of increased capillary permeability (hematocrit increased by 
≥20%), pleural effusion or ascites (by chest radiography or 
ultrasonography), or hypoalbuminemia. 
Dengue shock syndrome criteria include those for dengue hemorrhagic 
fever as well as hypotension, tachycardia, narrow pulse pressure 
(≤20 mm Hg), and signs of poor perfusion 
Unresolved FWS 
Those who had self limiting illness and their initial work up is negative is 
considered as probable viral fever. 
 
 
 
Observations 
Age and sex distribution of children presenting with fever without focus 
 
 
Male to Female to ratio: 1.3:1 
Majority of the children were < 1 year old. 
 
 
 
 
 
 
 
 
 
 
Age 1 – 3 months 4 -36 months Total 
Male 26(12.44%) 92(44.02%) 118(56.45%) 
Female 20(9.56%) 71(33.97%) 91(43.54%) 
Total 46(22%) 163(77.99%) 209(100%) 
Diagnosis and age distribution of children presenting with fever without 
focus 
Age 1 - 3months 4 -36 months Total percent 
Diagnosis No of 
cases 
Percent No of 
cases 
Percent   
Abscess 0 0.0% 1 0.61% 1 0.47% 
Bacteremia 4 8.69% 11 6.75% 15 7.17% 
Dengue 0 0.0% 33 20.24% 33 15.79% 
Enteric Fever 0 0.0% 2 1.23% 2 0.96% 
Leptospirosis 0 0.0% 5 3.06% 5 2.39% 
Malaria 2 4.34% 11 6.75% 13 6.22% 
Meningitis 2 4.34% 2 1.23% 4 1.91% 
Myocarditis 0 0% 1 0.61% 1 0.47% 
Pneumonia 3 6.52% 11 6.75% 14 6.86% 
Septic arthritis 1 2.17% 1 0.61% 2 0.96% 
UTI 4 8.7% 14 8.59% 18 8.61% 
Unresolved 
FWS 
30 65.21% 71 43.55% 101 48.33% 
TOTAL 46 100% 163 100% 209 100% 
 
 
 
 
 
Diagnosis and sex distribution of fever without localising sign 
 
 
 
 
 
 
 
Children with Bacteremia presented as fever without localising sign. 
 
Age 1 – 3 months 4- 36 months Total 
Male 2(13.33%) 7(46.67%) 9(60%) 
Female 2(13.33%) 4(26.67%) 6(40%) 
Total 
 
4(26.67%) 11(73.33%) 
 
15(100%) 
 
           bacteremia was found in 7.17 %. Prevalence of bacteremia is 
higher in 1- 3 months age group. Empirical antibiotic with ceftriaxone 
was started on 12 children who are seriously ill.   
 One among the 15 children had associated pneumonia 
10 out 15(66.66) patients showed leukocyte count> 15000/mm
3
 
 
 
 
 
 
 
 
 
 
Profile of organism isolated from blood culture 
 
Organism  No of isolates 
(N=15) 
1 – 3 months 4 -12 months 
Klebsiella 7(46.6%) 2 5 
Staphylococcus areus 4(26.6% 2 2 
E.coli 2(13.3%) 2 0 
Pseudomonas 1(6.6%) 0 1 
B haemolytic 
streptococci 
1(6.6%) 1 0 
 
 In klepsiella 5 isolates were sensitive to ciproflaxacin and 
Amikacin. 1 isolate showed moderate resistance to ciprofloxacin. 3 
out of 7 isolates were resistant to cefotaxime. 1 isolate showed 
resistant to ciprofloxacin, amikacin, cefotoxime but that was 
sensitive to imipenam. 
 In staph.areus 3 were sensitive to cloxacillin, amikacin and 
vancomicin. One isolate showed resistance to cloxaxacillin but 
sensitive to vancomycin. 
 In E.coli both the isolates were sensitive to cefotaxime and 
amikacin. 
 Pseudomonas showed sensitivity to amikacin and ciprofloxacin 
 Beta haemolytic streptococci was sensitive to penicillin, 
cloxacillin, cefotaxime, and vancomicin. 
 
Children with UTI presented as fever without localising sign. 
 
Age 1 – 3 months 4-36 months Total 
Male 2(11.11%) 6(33.33%) 8(44.44%) 
Female 2(11.11%)  8(44.44%) 10(55.56%) 
Total 4(22.22%) 14(77.77%) 18(100%) 
 
         UTI was the most common infection bacterial infection. Females 
are more often affected than male children. Children below 3 months of 
age there is no sex difference. E.coliwas the most the most common 
organism isolated.  All the males were uncircumcised. 2 out of 9 males 
had associated phimosis.   
9 out 18 patients showed WBC > 15000/mm
3 
 
 
 
 
 Profile of organism isolated from urine culture 
 
 Most common organism isolated was E.coli. 7 out of 9 isolates 
were sensitive to ciprofloxacin, amikacin and cefotaxime. 1 was 
sensitive to ciprofloxacine alone.  1 isolate was resistant to 
ciprofloxacin and amikacin, cefotaxime but sensitive to imipenam. 
 In klepsiella 5 out of 7 isolates were sensitive to ciprofloxacin and 
amikacin, cefotaxime. 1 out of 7 showed moderate resistance to 
amikacin. one isolate was sensitive to ciprofloxacin and amikacin 
 Pseudomonas showed sensitive to ciprofloxacin and amikacin 
 Proteus showed sensitive to ciprofloxacin and amikacin 
 
 
 
Organism No of isolates 
(N=18) 
1- 3 months 4-12 months 
E.Coli 9(43.47%) 2 6 
Klepsiella 7(34.78%) 1 6 
Pseudomonas 1(13.04%) 0 1 
Proteus 1(8.7%) 0 1 
  
Children with pneumonia presenting as fever without localising sign. 
 
Age 1 – 3 months 4 -36 months Total 
Male 1(7.14%) 7(50%) 8(57.14%) 
Female 2(14.29%) 4(28.57%) 6(42.85%) 
Total 3(21.43%) 11(78.57%) 14(100%) 
 
 Prevalence of occult pneumonia was same in both the age groups. They 
presented with fever andnonspecific symptoms like refusal feeds and 
lethargy. X- ray showed patchy pneumonia in all the patients. All the 
patients were treated with inj. Ampicillin. All were responded very 
well.12 out of 15 (80%)patients showed leukocyte count > 15,000/mm
3
 
 
 
 
 
 
 
 
 
  
 
Children with malaria presented as fever without localising. 
 
Age 1 – 12 months 25-36 months Total 
Male 1(7.69%) 4(30.76%) 5(38.46%) 
Female 1(7.69%) 7(53.85%) 8(61.54%) 
Total 2(15.38%) 11(84.61%) 13(100%) 
 
Malaria was found in 4.24% of cases. 12 cases were due to plasmodium 
vivax and 1 case due to plasmodium falciferum. Peripheral smear for 
malarial parasite was positive in 10 cases. QBC was positive in about 3 
cases. All cases responded well to chloroquine.   
 
 
 
 
 
 
 
 
  
Children with meningitis presenting as fever without localising sign 
Age 1 – 3 months 4  -36 months Total 
Male 2(50%) 1(25%) 3(75%) 
Female 0(0%) 1(25%) 1(25%) 
Total 2(50%) 2(50%) 4(100%) 
 
Lumbar puncture was done in those children with irritability and had 
seizures. In 1 child CSF latex agglutination for hemophilus influenza was 
positive. In other 3 children diagnosis was made by CSF cytology and 
biochemistry. 
 
 
 
 
 
 
 
 
 
 
  
Age sex distribution of children with dengue fever 
Age 1 – 3 months 13-36 months Total 
Male 0(0.0)% 20(60.1%) 20(60.61%) 
Female 0(0.0%) 13(39.39%) 13(39.39%) 
Total 0(0.0%) 33(100%) 33(100%) 
 
Dengue fever was the second most common cause of fever without 
localising signs. It represented 15.79% of total cases. 25 children 
recovered without shock. 5 children presented with shock at admission. 
3children developed shock and 6 developed petechial rash after 
admission.  
 
 
 
 
 
 
 
 
 
  
Age and sex distribution of leptospirosis in children presenting with fever 
without localising sign 
Age 1 – 3 months 13 -36 months Total 
Male 0(0%) 4(80%) 4(80%) 
Female 0(0%) 1(20%) 1(20%) 
Total 0(0%) 4(80%) 5(100%) 
 
3.2% of cases are due to leptospirosis. All the patients were treated with 
crystalline penicillin. 2 children had enteric fever. Both were treated with 
inj.ceftrixone. 1 child had ASOM. 2 children had septic arthritis.  
 
 
 
 
 
 
 
 
 
 
  
Age and sex distribution of unresolved FWS 
 
Age 1 – 3 months 13-36 months Total 
Male 17(16.83%) 42(41.58%) 59(58.41%) 
 
Female 13(12.87%) 29(28.71%) 42(41.58%) 
 
Total 30(29.7%) 71(70.29%) 101(100%) 
 
In about 101 (48.33)patients no focus was identified. Since these children 
had self limiting illness viral fever was considered as etiology.  
20 out of 101 showed WBC count > 15,000/mm
3
 
 
 
 
 
 
 
 
Discussion 
           The present Study was conducted in children who aged 
between1month to 36 months of age admitted in institute of child health 
with fever without localising sign.  During the study period 837 cases was 
identified as having fever without localising sign. Among these 209 
children who met inclusion and exclusion criteria.      
            Out of 209 patients 62 patients (29.66%) had serious bacterial 
infection. In 101(48.33%) patients focus was not identified. Since they 
had self limiting illness probable viral illness other than dengue was 
considered. Among the patients with serous bacterial infection UTI was 
the most common serious bacterial infection which was found in 
18(8.61%) cases. Bacteremia was found in 15(7.17%) patients. Other 
bacterial infection include occult pneumonia in 14 (6.86%) cases, 
bacterial meningitis in 5 (2.39%), septic arthritis 1n 2 patients(0.96%), 
leptospirosis in 5(2.39%), enteric fever in 2 (0.96%) patients. Malaria was 
found in13 cases (6.22%). Dengue was diagnosed in 33 cases (15.79%). 
           Incidence of serous bacterial infection various quit high (28.2%) in 
our population compared to western studies
37,38
.  In a similar study 
conducted by Vinchurkar et al
23 
in 2002 in 2002 showed  serious bacterial 
infection in 36.2 % of cases.not many studies available in india. Another 
study conducted by Omolola et al in Nigeria in 2002 showed 39% of 
bacteremia in 1- 12months age. The epidemiology of bacterial infections 
ever changing in children.
39
 Bacteremia was found in 12 patients (7.17%). 
prevalence of bacteremia in children is 5%
18
 in 1 -3 months age group. In 
this study it was 8.69%. 
          Prevalence bacteremia in 3month – 12 month was 4.9%. Most of 
the bacteremia was due to gram negative bacteria.  Klepsiella was the 
most common organism isolated. Staph areus was the second most 
common organism isolated.  Study done by Vinchurkar S et all found 
staph.areus as the most common agent. George O. Akpede, et al
25
 in 1992 
in Nigeria studied Six-hundred-and-forty-two previously healthy children 
aged 1 month to 5 years with fever without localizing signs of infection. 
Their study showed Gram-negative bacteraemia was overall commoner 
than Grampositivebacteraemia,Staphylococcus aureus was the 
commonest single organism. Study conducted by Omolola et al 1n 
Nigeria 2002 showed Escherichia coli (35.9%), Staphylococcus 
aureus(33.3%). Many western studies
39,40 
showed stretocooci pneumonia 
as most common organism causing bacteremia. In this study no isolate of 
streptococcus pneumonia was identified 
            UTI was most common bacterial infection in both the age group. 
As in other studies females are more commonly affected than males. It 
was found in 18(8.61%) patients. Prevalence of UTI was same in both the 
age groups. B. M. Machado et al 
21 
studied 251 children with fever 
without localising sign in 2009 in brazil. It showed UTI in 16 cases 
(7.4%). R.K. Kaushal et al 
32
studied 131 children upto five years of age 
presenting with fever of >38ºC for from November 1997 to October 1998 
in the Department of Pediatrics, IGMC, Shimla showed that the incidence 
of UTI was 8.4% (). The incidence was 6.1% in boys, 12.2% in girls, 
12.3%  in infants and 5.4%  in 13-60 months age group respectively.The 
incidence of UTI was 33.3%  among children presenting with urinary 
symptoms and 4.3%  in those with ARI. 
 
          Robert H. et al
29
 studied in U.S, 3066 infants aged 3 months or 
younger with temperatures of at least 38°C. They found UTI in 5.4% 
cases. Morris CM
26
, Te conducted a prospective study to document the 
importance of urinary tract infection (UTI) as a cause of fever without a 
focus (FWF) in children less than 3 years of age. UTI was diagnosed on 
urine culture in 9(9.2%) of the 98 children. E.coli was the most common 
organism isolated. Klepsiella was the second most common organism 
isolated. Most of the isolates were sensitive to amikacin ciproflaxacin 
           occul Shah
31
, studied 1866 patients 308 had no evidence of 
respiratory distress or lower respiratory tract findings and were studied 
for Occult pneumonia. Twenty-one patients had Occult pneumonia 
(6.8%; 95% confidence interval [CI], 4.0%-10.6%). Occult pneumonia 
was diagnosed in 14 (6.86) % of children which was similar to above 
study studies. 
           Bacterial meningitis was found  in 4(1.9%) patients. H. infleuenza 
was the causative organism in 1 patient.in other 3 no osgasm was 
isolated.  Z. Nademi el al studied One hundred and forty one children 
between 8 days and 16 years of age.  They found that 44%  of 
microbiologically proven meningitis and sepsis and 36%  of all 
meningitis and sepsis were meningococcal. Robert H. et al 
29
studied in 
united states 3066 infants aged 3 months or younger with temperatures of 
at least 38°C. Their study found bacteremia in 1.8% of infants (2.4% of 
those tested) and bacterial meningitis in 0.5%.  
          Murphy CG, studied two thousand one hundred twenty-eight 
patients .Among patients categorized as having no signs of pneumonia 
5.3% had occult pneumonia. 
          Malaria was seen in 13(6.22%) patients. Prevalence malaria 
increased with increasing age. 12 cases were due to vivax malarae and 
1was falciferum malaria infection. George O. Akpede, et al studied Six-
hundred-and-forty-two previously healthy children aged 1 month to 5 
years with fever without localizing signs of infection.Sixty-three per cent 
had malaria, 4 per cent bacteraemia, and 7 per cent malaria and 
bacteraemia. The prevalence of malaria increased with age while that of 
bacteraemia decreased with age neither infectionwas identified in 27 per 
cent. Rajnish Joshi et al  who studied 1671 patients above 12 yr of age. 
Malaria was present in 144 (12%) of patients as acute cause of fever. 
Sarala rajaji et al from chennai in their study of 75 children has found 
malaria as the cause of fever in 11 children. Prevalence of malaria in our 
study is lower than above study  
           Leptosirosis was found 5 cases (2.39 %). No case was seen in 1to 
3month age group   Koteeswaran
36
 in a large study conducted between 
2004 to2006 in tamilnadu showed the sero prevalence of leptospirosis 
was 11. 41% in under 5 age group. Leptospirosis is an important cause of 
acute febrile illness. Its  incidence and prevalence is increasing in recent 
years and becoming  as global health problem. 
           Dengue fever was diagnosed in 33(15.79%) patients. There was an 
epidemic of dengue during the study period. L kapilan et al 
42 
found 
dengue in 74.5% (143) of 192 admission with clinical dengue. A 
considerable proportion of dengue fever (20%) was found in infants of 
age < 1yr. 
 
 
 
 
 
 
 
 
Summary 
 A prospective study was conducted in children aged 1 month to 36 
months of age. 209 children who presented with fever without 
localising sign were included for the study. Out of 209 patients 118 
patients were male 91 were female. In all children relevant 
investigations were done to identify the focus of the infection. 
 Out of 209 patients 62 patients (29.66%) had serious bacterial 
infection.  
 In 100(47.84%) patients focus was not identified. Since they had 
self limiting illness probable viral illness was considered.     
 Among the patients with serous bacterial infection UTI was the 
most common serious bacterial infection which was found in 
18(8.61%) cases. E. Coli was the most common organism isolated. 
Most of the isolates were sensitive to amikacin  and ciprofloxacin. 
 Bacteremia was found in 15(7.17%) patients. Klepsiella was the 
most common organism isolated. Staph. Areus was the second 
most common organism isolated. Most of the isolates were 
sensitive to amikacin. 
 occult pneumonia in 14 (6.86%) cases. They presented only with 
fever and non specific symptoms like lethargy and refusal of feeds.  
 bacterial meningitis  was found in 2.39% of cases. In 1 patient CSF 
latex agglutination for H.infleunza was positive.  
 Other bacterial infections include ,septic arthritis in 2 
patients(0.96%) 
 Leptospirosis in 5(2.39%), enteric fever in 2 (0.96%) patients.  
 Malaria was found in13 patients (6.22%). 11 out of 13  were due to 
plasmodium vivax. 2 were due to plasmodium falciferum. Al cases 
responded well to chlroquine. 
 Dengue fever was diagnosed in 33 patients (15.79%). 
 
 
 
 
 
 
 
 
 
 
 
 
Conclusion  
 To conclude serious bacterial was found in 29.66% of cases and 
UTI was the most common SBI.  
 Any child between 1 to 36 months who present with toxic 
symptoms should be evaluated for the presence serious bacterial 
infections in the age group of 1 to 36 months.  
 Gram negative bacteremia is more common than gram positive. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Limitations of the study: 
Study was conducted in a tertiary referral center were mostly sick 
children are got admitted. Prevalence of bacteremia may not applicable to 
in children who presents with fever without localising sign in children 
coming to out patient department. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
Recomendations 
 
 
 
 
 
 Most of the isolates both from urine and blood were susceptible to 
Amikacin and ciproflaxacin. 
 Staphylococcus areus was the second most common organism 
causing bacteremia. Many isolates were sensitive to amikacin 
 Further large scale studies are needed to confirm these findings.  
Choice of empirical antibiotic in  a toxic febrile child without 
localising sign  need to be revised  
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Annexure - I 
 
Data collection form 
 
Name: 
 
Age 
 
Study S.No: 
 
Sex: 
 
Address: 
 
Symptoms 
 
Fever:  Duration 
                
            Character 
 
            Chills / Rigor 
 
H/O present illness 
 
 
Treatment history:  prior antibiotic intake yes / no 
                                                If yes oral / parenteral             duration 
 
H/O Past illness  
 
Diet History 
 
Immunization History 
 
General Examination: 
   
1. Consious       2. Oriented    3. Tachypneic 
 
4. Dyspnoeic.  5. Cyanosis   
  
 
 Temperature 
 
Vitals:                      Pulse:                              Respiratory rate: 
 
 
 
 
 
System Examination:  
 
CVS 
 
RS 
 
Abdomen 
 
CNS 
 
 
Final Diagnosis 
 
 
Investigations:  
  
Total WBC count 
 
Differential count 
 
Platelet Count 
 
Peripheral smear  
 
Urine routine 
 
Chest X ray 
 
Urine C&S  
 
Blood C&S 
 
CSF analysis 
 
Others 
 
 
 
 
 
 
 
 
 
 
 
Annexure - II 
 
Information to Participants 
 
Investigator: Dr Sangeeth S 
 
Name of Participant: 
 
Title: Etiological profile of fever of short duration without focus in children aged 
1 month to 36 months 
 
You are invited to take part in this research/ study /procedures. The information in 
this document is meant to help you decide whether or not to take part. Please feel free 
to ask if you have any queries or concerns. You are being asked to participate in this 
study being conducted in  Institute of Child health and Hospital for children. 
 
What is the Purpose of the Research Febrile infants and children frequently present 
to primary care and emergency physicians. The majority of these children are younger 
than 3 years. Most have an apparent source of infection (ie, a viral respiratory 
infection, acute otitis media, or enteritis). This study aims to find out etiology of fever 
of short duration without foci 
We have obtained permission from the Institutional Ethics Committee. 
 
Study design:  Descriptive study 
 
Study Procedures 
1. Sick child aged 1 to 36 months who got admitted in ICH with fever of short 
duration will be enrolled for study 
2 Child who present without focus blood culture, urine culture, chest x ray, will be 
done  
3. Further investigation will be done to arrive at diagnosis  
Possible risks  - Briefly Mention (if any)  
 
Possible benefits to you (if any): Identification of focus of infection 
 
Possible benefits to other people 
The result of the research may provide benefits to the society in terms of advancement 
of medical knowledge and/or therapeutic benefits to future patients. 
 
Confidentiality of the information obtained from you 
You have the right to confidentiality regarding the privacy of your medical 
information (personal details, results of physical examinations, investigations, and 
child  medical history). By signing this document, you will be allowing the research 
team investigators, other study personnel, sponsors, IEC and any person or agency 
required by law like the Drug Controller General of India to view your data, if 
required. The information from this study, if published in scientific journals or 
presented at scientific meetings, will not reveal your identity. 
 
 
  
How will your decision to not participate in the study affect you? 
Your decisions to not participate in this research study will not affect child‘s medical 
care or your relationship with investigator or the institution. Your doctor will still take 
care of your child and your child will not loose any benefits to which you are entitled. 
 
Can you decide to stop participating in the study once you start? 
The participation in this research is purely voluntary and you have the right to 
withdraw from this study at any time during course of the study without giving any 
reasons. However it is advisable that you talk to the research team prior to stopping 
the treatment. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INFORMED CONSENT FORM 
 
Study: “Etiological profile of fever of short duration without focus in children 
aged 1 to 36 months‖. 
 
Name of the Participant:   
 
Name of the Principal :  Dr. Sangeeth S 
 
Name of the Institution: Institute of Child Health and Hospital for Children 
 
Documentation of the informed consent 
I _____________________________ have read the information in this form (or it has been 
read to me). I was free to ask any questions and they have been answered. I hereby give my 
consent to be included as a participant in‖ Etiological profile of fever of short duration 
without focus in children aged 1 to 36 months‖.  
1. I have read and understood this consent form and the information provided to me. 
2. I have had the consent document explained to me. 
3. I have been explained about the nature of the study. 
4. I have been explained about my rights and responsibilities by the investigator. 
5. I have been informed the investigator of all the treatments given to my child taken in the 
past ________ months including any native (alternative) treatment 
6. I have been advised about the risks associated with my child‘s participation in this study.* 
7. I agree to cooperate with the investigator and I will inform him/her immediately if my child 
suffers from unusual symptoms 
8. My child has not participated in any research study within the past ________month(s).  
9. I am aware of the fact that I can opt out of the study at any time without having to give any 
reason and this will not affect future treatment in this hospital.  
10. I am also aware that the investigator may terminate my participation in the study at any 
time, for any reason, without my consent.  
11. I hereby give permission to the investigators to release the information obtained from me 
as result of participation in this study to the sponsors, regulatory authorities, Govt. agencies, 
and IEC. I understand that they are publicly presented. 
12. I have understand that my child‘s identity will be kept confidential if my data are publicly 
presented 
13. I have had my questions answered to my satisfaction. 
9. I have decided  my child to be in the research study.  
10. I am aware that if I have any question during this study, I should contact the investigator. 
By signing this consent form I attest that the information given in this document has been 
clearly explained to me and understood by me, I will be given a copy of this consent 
document. 
 
 
 
 
 
 
 
 
Although your child did not or could not give his or her assent, you agree to your 
child‘s participation in this study. 
 Name and Signature of / thumb impression of the participant‘s parent(s) (or legal 
representative) 
 
 
Name ______________Signature_________________ Date____________ 
 
Name ______________Signature_________________ Date____________ 
 
 
Name and Signature of impartial witness (required for parents of participant child 
illiterate): 
 
Name _____________Signature_________________ Date____________ 
 
Address and contact number of the impartial witness: __________________ 
 
 
Name and Signature of the investigator or his representative obtaining consent: 
Name _____________Signature_________________ Date______________ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

: 
: :
: :
: : 
Abbrevations 
 
 
  CBC          Complete blood count  
 
 CI              Confidence interval 
 
CSF             Cerebrospinal fluid  
 
FWS            Fever without localising sign 
 
HPF            High-powered field  
 
LR               Likelihood ratio 
 
RBC            Red blood cell  
 
UTI            Urinarytract infection    
 
WBC          White blood cell 
 
 
 
 
 
 
 
 
 
